# A Phase 1 Study of TDM-105795 Topical Solution in Male Subjects With Androgenetic Alopecia (AGA)

> **NCT04913519** · PHASE1 · COMPLETED · sponsor: **Technoderma Medicines Inc.** · enrollment: 30 (actual)

## Conditions studied

- Alopecia, Androgenetic

## Interventions

- **DRUG:** TDM-105795
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04913519
- **Lead sponsor:** Technoderma Medicines Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-04-27
- **Primary completion:** 2021-12-31
- **Final completion:** 2021-12-31
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2022-04-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04913519

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04913519, "A Phase 1 Study of TDM-105795 Topical Solution in Male Subjects With Androgenetic Alopecia (AGA)". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT04913519. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*